Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Publications: Chen, Suxiang

Stats for Chen, Suxiang
Export as [feed] RSS
Group by: Item Type | Year
Number of items: 24.

Journal Article

Tan, Y., Zheng, T., Zhang, R., Chen, S., Cheng, Q., Zhang, J., Wang, R., Chen, M. and Na, N. (2022) Alternative polyadenylation writer CSTF2 forms a positive loop with FGF2 to promote tubular epithelial-mesenchymal transition and renal fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1868 (12). Art. 166541.

Li, Y., Tan, Y., Zhang, R., Wang, T., Na, N., Zheng, T., Veedu, R.N. and Chen, S. (2022) Antisense oligonucleotide: A potential therapeutic intervention for chronic kidney disease. Kidney and Dialysis, 2 (1). pp. 16-37.

Chen, S. (2022) Blotting: A smart strategy for enabling the detection of molecules of interest. OALib, 09 (08). pp. 1-6.

Chen, L., Wang, J., Cai, X., Chen, S., Zhang, J., Li, B., Chen, W., Guo, X., Luo, H. and Chen, J. (2022) Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. Bioorganic Chemistry, 119 . Art. 105516.

Chen, S. (2022) Discovery, invention, and innovation: Are they really different? Academia Letters .

Raguraman, P., Balachandran, A.A., Chen, S., Diermeier, S.D. and Veedu, R.N. (2021) Antisense oligonucleotide-mediated splice switching: Potential therapeutic approach for cancer mitigation. Cancers, 13 (21). Article 5555.

Chen, J., Deng, Y., Wang, J., Chen, S., Peng, F., He, X., Liu, M., Luo, H., Zhang, J. and Chen, L. (2021) Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling. JBIC Journal of Biological Inorganic Chemistry .

Wang, T., Chen, L., Chikkanna, A., Chen, S., Brusius, I., Sbuh, N. and Veedu, R.N. (2021) Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis. Theranostics, 11 (11). pp. 5174-5196.

Chen, S., Sbuh, N. and Veedu, R.N. (2020) Antisense oligonucleotides as potential therapeutics for Type 2 Diabetes. Nucleic Acid Therapeutics, 31 (1). pp. 39-47.

Chen, S., Le, B.T., Chakravarthy, M., Kosbar, T.R. and Veedu, R.N. (2020) Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro. Scientific Reports, 10 (1). Art. 6669.

Hamulati, H., Chen, S., Gu, Z., Sun, Y. and Wang, T. (2020) Development of a total flavonoids extract of Artemisia Rupestris L. via nanotechnology and its antiviral effect In Vitro. Infectious Diseases Research, 1 (2).

Chakravarthy, M., Chen, S., Wang, T. and Veedu, R.N. (2020) Development of novel chemically-modified nucleic acid molecules for efficient inhibition of human MAPT gene expression. Genes, 11 (6). Article 667.

Yang, D., Zhang, W., Zhang, H., Zhang, F., Chen, L., Ma, L., Larcher, L.M., Chen, S., Liu, N., Zhao, Q., Tran, P.H.L., Chen, C., Veedu, R.N. and Wang, T. (2020) Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics, 10 (8). pp. 3684-3707.

Balachandran, A.A., Larcher, L.M., Chen, S. and Veedu, R.N. (2020) Therapeutically significant MicroRNAs in primary and metastatic brain malignancies. Cancers, 12 (9). Article 2534.

Li, Y., Chen, S., Liu, N., Ma, L., Wang, T., Veedu, R.N., Liu, T., Zhang, F., Zhou, H., Cheng, X. and Jing, X. (2020) A systematic investigation of key factors of nucleic acid precipitation toward optimized DNA/RNA isolation. BioTechniques, 68 (4). pp. 191-199.

Chen, S., Le, B.T., Chakravarthy, M., Kosbar, T.R. and Veedu, R.N. (2019) Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro. Scientific Reports, 9 (1). Article number 6078.

Chakravarthy, M., Al Shamaileh, H., Huang, H., Tannenberg, R.K., Chen, S., Worrall, S., Dodd, P.R. and Veedu, R.N. (2018) Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro. Chemical Communications, 54 (36). pp. 4593-4596.

Hassanzadeh, L., Chen, S. and Veedu, R. (2018) Radiolabeling of nucleic acid aptamers for highly sensitive disease-specific molecular imaging. Pharmaceuticals, 11 (4). p. 106.

Chakravarthy, M., Chen, S., Dodd, P.R. and Veedu, R.N. (2017) Nucleic acid-based theranostics for tackling Alzheimer's Disease. Theranostics, 7 (16). pp. 3933-3947.

Le, B.T., Chen, S., Abramov, M., Herdewijn, P. and Veedu, R.N. (2016) Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro. Chemical Communications, 52 (92). pp. 13467-13470.

Lipi, F., Chen, S., Chakravarthy, M., Rakesh, S. and Veedu, R.N. (2016) In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies. RNA Biology, 13 (12). pp. 1232-1245.

Chen, S., Le, B.T., Rahimizadeh, K., Shaikh, K., Mohal, N. and Veedu, R.N. (2016) Synthesis of a morpholino nucleic acid (MNA)-Uridine phosphoramidite, and exon skipping using MNA/2′-O-Methyl mixmer antisense oligonucleotide. Molecules, 21 (11). p. 1582.


Chen, Suxiang (2020) Development of novel chemically modified antisense oligonucleotides for tackling type 2 diabetes and Duchenne muscular dystrophy. PhD thesis, Murdoch University.


Veedu, R.N. and Chen, S. (2020) Antisense therapy for PTP1B related conditions. Patent. WRAYS PTY LTD, WO/2020/077390 .

This list was generated on Sat Jan 28 17:49:31 2023 UTC.